| Income Statement | 2025-09-30 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total net revenues | 4,764 | 3,518 | 3,252 | |
| Cost of goods sold | 1,849 | 1,369 | 1,340 | |
| Gross margin | 2,915 | 2,149 | 1,912 | |
| Selling, general and administrative | 2,229 | 1,721 | 1,941 | |
| Research and development | 338 | 188 | 254 | |
| Depreciation and amortization | 34 | 34 | 34 | |
| Total operating expenses | 2,601 | 1,943 | 2,229 | |
| Operating income (loss) | 314 | 206 | -317 | |
| Interest income | 41 | 20 | 21 | |
| Other (expense), net | -15 | -43 | 7 | |
| Total other expense (income), net | 26 | -23 | 28 | |
| Income (loss) before income taxes | 340 | - | - | |
| Income tax expense | 3 | - | - | |
| Net income (loss) | 337 | 183 | -289 | |
| Net income (loss) per common share, basic | 0.03 | 0.02 | -0.03 | |
| Net income (loss) per common share, diluted | 0.03 | 0.02 | -0.03 | |
| Weighted average common shares outstanding, basic | 10,612,012 | 10,544,139 | 10,509,937 | |
| Weighted average common shares outstanding, diluted | 11,040,925 | 10,580,906 | 10,509,937 | |
NEPHROS INC (NEPH)
NEPHROS INC (NEPH)